Antidiabetic effects of duodenojejunal bypass in an experimental model of diabetes induced by a high-fat diet

British Journal of Surgery

Volumn 98, Issue 5, 2011, Pages 686-696

  Woods, M ^a   Lan, Z ^a,b   Li, J ^a   Wheeler, M B ^c   Wang, H ^a,b   Wang, R ^a,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Victoria Research Laboratories   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GLUCAGON LIKE PEPTIDE 1; HOMEODOMAIN PROTEIN; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; TRANSACTIVATOR PROTEIN;

ANASTOMOSIS; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; C57BL MOUSE; DIET; DUODENUM; EATING; FAT INTAKE; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; JEJUNUM; METABOLISM; MOUSE; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PATHOLOGY;

ANASTOMOSIS, SURGICAL; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLECYSTOKININ; DIABETES MELLITUS, TYPE 2; DIET; DIETARY FATS; DUODENUM; EATING; FLUORESCENT ANTIBODY TECHNIQUE; GLUCAGON-LIKE PEPTIDE 1; HOMEODOMAIN PROTEINS; HOMEOSTASIS; ISLETS OF LANGERHANS; JEJUNUM; MICE; MICE, INBRED C57BL; MICE, OBESE; TRANS-ACTIVATORS;

EID: 79953712625     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7400     Document Type: Article

References (30)

1. Rubino F,. Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care 2006; 9: 497-507. (Pubitemid 44097824)
2. Pender C, Goldfine ID, Tanner CJ, Pories WJ, MacDonald KG, Havel PJ, et al., Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia. Int J Obes Relat Metab Disord 2004; 28: 363-369. (Pubitemid 38296948)
3. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J,. Outcomes after laparoscopic Roux-en- $\font\ss=cmss10 scaled 1000 \hbox{Y}$ gastric bypass for morbid obesity. Ann Surg 2000; 232: 515-529.
4. Rubino F, Marescaux J,. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 1-11. (Pubitemid 38176365)
5. Pacheco D, de Luis DA, Romero A, González Sagrado M, Conde R, Izaola O, et al., The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg 2007; 194: 221-224. (Pubitemid 47008973)
6. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al., The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741-749. (Pubitemid 44629948)
7. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M,. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008; 4: 55-59.
8. Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F,. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 2007; 3: 195-197. (Pubitemid 46444706)
9. 2 (LBMI). Obes Surg 2009; 19: 307-312.
10. Liu W, Zassoko R, Mele T, Luke P, Sun H, Liu W, et al., Establishment of duodenojejunal bypass surgery in mice: a model designed for diabetic research. Microsurgery 2008; 28: 197-202. (Pubitemid 351458270)
11. Lan Z, Zassoko R, Liu W, Garcia B, Sun H, Wang R, et al., Development of techniques for gastrojejunal bypass surgery in obese mice. Microsurgery 2010; 30: 289-295.
12. Krishnamurthy M, Ayazi F, Li J, Lyttle AW, Woods M, Wu Y, et al., c-Kit in early onset of diabetes: a morphological and functional analysis of pancreatic beta-cells in c-KitW-v mutant mice. Endocrinology 2007; 148: 5520-5530. (Pubitemid 350012638)
13. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN,. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988; 37: 1163-1167. (Pubitemid 19035045)
14. Van Itallie TB, Beaudoin R, Mayer J,. Arteriovenous glucose differences, metabolic hypoglycemia and food intake in man. J Clin Nutr 1953; 1: 208-217.
15. Meier JJ, Butler AE, Galasso R, Butler PC,. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 2006; 29: 1554-1559. (Pubitemid 44127580)
16. Warne JP, Padilla BE, Horneman HF, Ginsberg AB, Pecoraro NC, Akana SF, et al., Metabolic and neuroendocrine consequences of a duodenal-jejunal bypass in rats on a choice diet. Ann Surg 2009; 249: 269-276.
17. Berthoud HR, Neuhuber WL,. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 2000; 85: 1-17.
18. Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, et al., Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 2006; 290: E550-E559. (Pubitemid 43671703)
19. Dirksen C, Hansen DL, Madsbad S, Hvolris LE, Naver LS, Holst JJ, et al., Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report. Diabetes Care 2010; 33: 375-377.
20. Jonsson J, Carlsson L, Edlund T, Edlund H,. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994; 371: 606-609. (Pubitemid 24315741)
21. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, et al., PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996; 122: 983-995. (Pubitemid 26096002)
22. Chen C, Fang R, Davis C, Maravelias C, Sibley E,. Pdx1 inactivation restricted to the intestinal epithelium in mice alters duodenal gene expression in enterocytes and enteroendocrine cells. Am J Physiol Gastrointest Liver Physiol 2009; 297: G1126-G1137.
23. Ekblad E, Sundler F,. Distribution of pancreatic polypeptide and peptide YY. Peptides 2002; 23: 251-261. (Pubitemid 34127963)
24. Taylor IL, Impicciatore M, Carter DC, Walsh JH,. Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs. Am J Physiol 1978; 235: E443-E447. (Pubitemid 9163016)
25. Schmidt PT, Näslund E, Grybäck P, Jacobsson H, Holst JJ, Hilsted L, et al., A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control. J Clin Endocrinol Metab 2005; 90: 5241-5246. (Pubitemid 41262281)
26. Ballantyne GH,. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 2006; 16: 795-803. (Pubitemid 43874841)
27. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, et al., Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108-114. (Pubitemid 43054062)
28. Lukinius A, Stridsberg M, Wilander E,. Cellular expression and specific intragranular localization of chromogranin A, chromogranin B, and synaptophysin during ontogeny of pancreatic islet cells: an ultrastructural study. Pancreas 2003; 27: 38-46. (Pubitemid 36775977)
29. Kellum JM, Kuemmerle JF, O'Dorisio TM, Rayford P, Martin D, Engle K, et al., Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990; 211: 763-770.
30. Schwarz A, Büchler M, Usinger K, Rieger H, Glasbrenner B, Friess H, et al., Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: prospective randomized clinical study. World J Surg 1996; 20: 60-66.